TisCRT-LAPC: A phase II study of tislelizumab combined with nab-paclitaxel and gemcitabine (AG) followed by consolidative radiotherapy in locally advanced pancreatic cancer (LAPC)

被引：0
作者：
Guo, Xi
Zhou, Yuhong
Ji, Yuan
Lou, Wenhui
Wu, Lili
Wang, Wenquan
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16350
引用
收藏
页数：1
相关论文
共 50 条
[21]   Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ± pamrevlumab (P) as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC). [J].
Picozzi, Vincent J. ;
Rocha, Flavio G. ;
Helton, Scott ;
Pishvaian, Michael J. ;
Jackson, Patrick G. ;
Mody, Kabir ;
Asbun, Horacio ;
Carney, Mairead ;
Etheridge, Tina ;
Neff, Thomas B. ;
Porter, Seth ;
Zhong, Ming ;
Valone, Frank ;
Kouchakji, Elias ;
Imperial, Joanne C. ;
Carrier, Ewa .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[22]   Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer [J].
Guo, Guifang ;
Li, Shengping ;
Mao, Yize ;
Yang, Qiuxia ;
Yao, Zehui ;
Wang, Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[23]   EFFICACY OF GEMCITABINE/NAB-PACLITAXEL INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER [J].
Takada, Ryoji ;
Ikezawa, Kenji ;
Kiyota, Ryosuke ;
Imai, Toshihiro ;
Yutaro, Abe ;
Fukutake, Nobuyasu ;
Takatoshi, Nawa ;
Katayama, Kazuhiro ;
Ohkawa, Kazuyoshi .
GASTROENTEROLOGY, 2020, 158 (06) :S865-S866
[24]   Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer [J].
Tsujimoto, Akiko ;
Sudo, Kentaro ;
Nakamura, Kazuyoshi ;
Kita, Emiri ;
Hara, Ryusuke ;
Takayama, Wataru ;
Ishii, Hiroshi ;
Yamaguchi, Taketo .
SCIENTIFIC REPORTS, 2019, 9 (1)
[25]   Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ±FG-3019 as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC). [J].
Picozzi, Vincent J. ;
Rocha, Flavio G. ;
Helton, Scott ;
Mody, Kabir ;
Asbun, Horacio ;
Pishvaian, Michael J. ;
Jackson, Patrick G. ;
Etheridge, Tina ;
Carney, Mairead ;
Neff, Thomas B. ;
Porter, Seth ;
Crans, Gerald ;
Valone, Frank ;
Shi, Wen .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[26]   Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer [J].
Okusaka, T ;
Ito, Y ;
Ueno, H ;
Ikeda, M ;
Takezako, Y ;
Morizane, C ;
Kagami, Y ;
Ikeda, H .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :673-677
[27]   Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer [J].
Akiko Tsujimoto ;
Kentaro Sudo ;
Kazuyoshi Nakamura ;
Emiri Kita ;
Ryusuke Hara ;
Wataru Takayama ;
Hiroshi Ishii ;
Taketo Yamaguchi .
Scientific Reports, 9
[28]   Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer [J].
T Okusaka ;
Y Ito ;
H Ueno ;
M Ikeda ;
Y Takezako ;
C Morizane ;
Y Kagami ;
H Ikeda .
British Journal of Cancer, 2004, 91 :673-677
[29]   A phase 1 study of neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel, followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in locally advanced pancreatic cancer [J].
Park, Haeseong ;
Poklepovic, Andrew .
CANCER RESEARCH, 2014, 74 (19)
[30]   Phase III PANOVA study of tumor treating fields (150 kHz) in combination with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC) [J].
Weinberg, Uri ;
Farber, Ori ;
Giladi, Moshe ;
Bomzon, Zeev ;
Kirson, Eilon .
CANCER RESEARCH, 2019, 79 (13)
12345